OTLK: Outlook Therapeutics Inc

OTLK新闻

• 14:18 Outlook Therapeutics股票在FDA接受BLA重新提交后飙升
• 14:17 Outlook Therapeutics stock soars after FDA accepts BLA resubmission
• 13:53 FDA将于2025年12月31日审查Outlook的湿性AMD药物
• 13:51 FDA sets Dec. 31 review date for Outlook’s wet AMD drug
• 13:49 Outlook Therapeutics重新提交湿性AMD治疗药物的BLA申请
• 13:45 Outlook Therapeutics resubmits BLA for wet AMD treatment
• 11:50 H.C. Wainwright维持Outlook Therapeutics股票中性评级
• 11:47 H.C. Wainwright maintains Neutral rating on Outlook Therapeutics stock
• 20:51 Brookline Capital将Outlook Therapeutics目标价从8美元上调至13美元
• 20:50 Outlook Therapeutics stock price target raised to $13 from $8 at Brookline Capital
• 15:53 Outlook Therapeutics股票在与FDA会议富有成效后大涨
• 15:52 Outlook Therapeutics stock surges after productive FDA meeting
• 12:59 Outlook Therapeutics计划向FDA重新提交湿性AMD治疗的BLA申请
• 12:54 Outlook Therapeutics plans FDA BLA resubmission for wet AMD treatment
• 14:38 OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug
• 11:41 Outlook Therapeutics stock rating downgraded by H.C. Wainwright on FDA rejection
• 20:30 U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16%
• 16:54 Nasdaq Surges 100 Points; Dollar General Earnings Beat Views - CaliberCos (NASDAQ:CWD), Accelerant Holdings (NYSE:ARX)
• 15:15 FDA Rejects Outlook Therapeutics Eye Drug For Second Time - Outlook Therapeutics (NASDAQ:OTLK)
• 14:27 US Stocks Mixed; Nvidia Posts Upbeat Earnings - CaliberCos (NASDAQ:CWD), AquaBounty Techs (NASDAQ:AQB)
• 11:40 US FDA declines to approve Outlook Therapeutics’ drug for eye condition
• 11:12 Outlook Therapeutics stock falls after FDA rejects wet AMD drug
• 10:05 Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Beneficient (NASDAQ:BENF), Bollinger Innovations (NASDAQ:BINI)
• 13:15 Why The Odds Point To A Favorable FDA Decision For Outlook (NASDAQ:OTLK)